Daniel McClernon has twenty-nine years of successful pharmaceutical industry experience in drug discovery, molecular diagnostics and business development. He is founder of McClernon, LLC which provides solutions in pharmaceutical, biomarker and clinical diagnostic development and is president of bioMONTR™ which is an infectious disease laboratory wholly owned by McClernon, LLC. As a former GlaxoSmithKline principal scientist, Daniel participated in antiviral and anti-infective drug development, including discovery, preclinical, and phases I-IV clinical development programs. He is a protocol virologist with extensive experience in assay development, drug resistance, clinical trial testing and NeuroAIDS research. He also leads numerous collaborative projects with major diagnostic companies for implementation/execution of molecular-based platforms.